期刊文献+

多囊卵巢综合征患者一级亲属代谢表型及心血管疾病风险的分析 被引量:7

Metabolic phenotype and cardiovascular risk factors in the first degree relatives of Chinese women with polycystic ovary syndrome
原文传递
导出
摘要 为明确多囊卵巢综合征(PCOS)患者一级亲属的代谢表型改变及心血管疾病风险是否升高,比较110名PCOS患者一级亲属与年龄及体重相匹配的85名非PCOS正常女性一级亲属的代谢表型和心血管疾病风险的差异。PCOS患者一级亲属中母亲和父亲的糖耐量受损发生率分别是51.4%和57.5%。与非PCOS对照的一级亲属相比,PCOS患者一级亲属中空腹胰岛素水平、稳态模型评估的胰岛素抵抗指数、胰岛素曲线下面积及超敏C反应蛋白水平明显升高,而胰岛素敏感指数和高分子量脂联素水平明显降低(P〈O.05)。PCOS患者的一级亲属中除姐妹外,父母亲及兄弟的总胆固醇、低密度脂蛋白胆固醇和甘油三酯水平明显高于正常对照组(P〈O.05)。PCOS患者一级亲属的代谢表型存在明显的胰岛素抵抗特征,即糖耐量受损、高脂血症、高炎症水平,提示其心血管疾病风险明显增高。 To test the hypothesis that the first degree relatives of Chinese women with polycystic ovarian syndrome (PCOS) have higher risk of cardiovascular disease than those without PCOS. The metabolic phenotype and risks of cardiovascular disease were evaluated in 110 family members of 35 women with PCOS and 85 unrelated healthy control subjects without family history of diabetes and PCOS (four age- and weight-matched subgroups ). The prevalence of impaired glucose tolerance was 51.4% in mothers and 57.5% in fathers with their daughters suffering from PCOS. The first degree relatives of PCOS women had significantly higher serum fasting insulin level, homeostasis model assessment for insulin resistance, insulin area under the curve, and lower insulin sensitivity index in all subgroups than the control subjects( P〈O. 05 ). The control subjects had significantly elevated high molecular weight- adiponectin levels and decreased high sensitive-C reactive protein levels compared to the first degree relatives of PCOS women in all subgroups. Parents and brothers, but not sisters, of women with PCOS had significantly higher total cholesterol and low density lipoprotein-cholesterol ( P〈0.05 ), as well as triglyceride levels ( P〈0.05 ), compared with control subjects. The first degree relatives of PCOS women had features of insulin resistance and increased risk of cardiovascular disease.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第4期315-318,共4页 Chinese Journal of Endocrinology and Metabolism
基金 上海市科委重点科技攻关项目(08411953000)
关键词 多囊卵巢综合征 一级亲属 胰岛素抵抗 心血管疾病 Polycystic ovarian syndrome First degree relatives Insulin resistance Cardiovascular disease
  • 相关文献

参考文献30

  • 1Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS) : arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab, 1999,84 : 1897-1899.
  • 2Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol, 2011,7:219-231.
  • 3Hoffman LK, Ehrmann DA. Cardiometabolie features of polyeystie ovary syndrome. Nat Clin Pract Endocrinol Metab, 2008,4:215-222.
  • 4Lo JC, Feigenbaum SL, Yang J, et al. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome. J Clin Endocrinol Metab, 2006,91:1357-1363.
  • 5Cussons AJ, Stuckey BG, Watts GF. Metabolic syndrome and cardiometabolic risk in PCOS. Curr Diab Rep, 2007,7:66-73.
  • 6Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med, 2008,26:39-44.
  • 7Azevedo GD, Duarte JM, Souza MO, et al. Menstrual cycle irregularity as a marker of cardiovascular risk factors at postmenopausal years. Arq Bras Endocrinol Metabol, 2006,50 : 876-883.
  • 8Nestler JE. Metformin for the treatment of the polycystic ovary syndrome. N Engl J Med, 2008,358:47-54.
  • 9Ehrman DA, Kasza K, Azziz R, et al. PCOS/Troglitazonc Study Group. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2005,90:66-71.
  • 10Yildiz BO, Yarali H, Oguz H, et al. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab, 2003,88 : 2031-2036.

二级参考文献67

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3070
  • 2Coviello AD,Legro RS,Dunaif A.Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.J Clin Endocrinol Metab,2006,91:492-497.
  • 3Cheung LP,Ma RC,Lam PM,et al.Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.Hum Reprod,2008,23:1431-1438.
  • 4Rossi B,Sukalich S,Droz J,et al.Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.J Clin Endocrinol Metab,2008,93:4780-4786.
  • 5Steering Committee of the Western Pacific Region of the World Health Organization,the International Association for the Study of Obesity,and the International Obesity Task Force.The Asia-Pacific Perspective:Redefining Obesity and its Treatment.Melbourne,Australia:Health Communications Australia Pty Ltd,2000.
  • 6Crundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome:an American Heart Association/National Heart,Lung,and Blood Institute Scientific Statement.Circulation,2005,112:2735-2752.
  • 7Asuncion M,Calvo RM,San Millan JL,et al.A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.J Clin Endocrinol Metab,2000,85:2434-2438.
  • 8Yildiz BO,Knochenhauer ES,Azziz R.Impact of obesity on the risk for polycystic ovary syndrome.J Clin Endocrinol Metab,2008,93:162-168.
  • 9Puder JJ,Varga S,Kraenzlin M,et al.Central fat excess in polycystic ovary syndrome:Relation to low-grade inflammation and insulin resistance.J Clin Endocrinol Metab,2005,90:6014-6021.
  • 10Yildirim B,Sabir N,Kaleli B.Relation of infra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome.Fertil Steril,2003,79:1358-1364.

共引文献88

同被引文献117

引证文献7

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部